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Abstract
This study examined the relationships between perceived public stigma, experienced stigma, and quality of life
in people living with HIV (PLHIV), and whether self-stigma mediates these relationships. Cross-sectional data
were analyzed from 1704 PLHIV in care at OLVG hospital in the Netherlands. We measured different types of
stigma (perceived public stigma, experienced stigma, and self-stigma), and various quality-of-life outcomes
(disclosure concerns, depression, anxiety, sexual problems, sleeping difficulties, self-esteem, general health, and
social support). Structural equation modeling was used to test the paths from different types of stigma to
quality-of-life outcomes. All direct effects of self-stigma on quality-of-life outcomes were significant. The final
mediation model showed that the effects of both perceived public and experienced stigma on quality-of-life
outcomes were mediated by self-stigma. These findings highlight the importance of addressing self-stigma in
PLHIV, and call for (psychosocial) interventions that reduce the harmful effects of HIV-related stigma.
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Introduction
HIV has gradually transitioned into a chronic ratherthan life-threatening condition as a result of major ad-
vances in treatment development and access to antiretroviral
therapy.1,2 However, despite significant improvements in
efforts to end the epidemic, critical issues for people living
with HIV (PLHIV) remain. Globally, HIV-related stigma
continues to be an important barrier to both effective HIV
treatment and prevention initiatives.3,4 Research further
suggests that stigma compromises the quality of life of
PLHIV.5–10 Quality of life is a multi-dimensional construct
that encompasses physical, psychological, and social di-
mensions of life.11
Literature on HIV-related stigma finds its roots in the early
work of Erving Goffman (1963),12 who defined stigma as
‘‘the discrediting of individuals based on an undesirable at-
tribute.’’(p3) Today, HIV-related stigma is characterized by
various forms of stigma that can be encountered by PLHIV,
including public stigma and self-stigma (also referred to as
internalized stigma).13,14 Public stigma entails the negative
beliefs held in society about HIV, negative emotional reac-
tions such as anger or disgust, and negative behaviors such as
avoidance or abuse toward PLHIV.15,16 Public stigma can be
perceived as well as experienced (i.e., discrimination or en-
acted stigma). Self-stigma occurs when a person with a
stigmatized condition is aware of public stigma, and inter-
nalizes the negative beliefs in society and accepts their
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validity.17–19 In this sense, self-stigma is the product of public
stigma. Previous studies have found that self-stigma mani-
fests in multiple ways including feelings of shame or feeling
dirty, as well as guilt and fear.20,21
Stigma, both public and self-stigma, is highly detrimental.
Stigma is linked to negative psychological, social, and
physical health outcomes (e.g., depression, anxiety, lower
self-esteem, disclosure concerns, reduced social support,
sexual problems, sleeping difficulties, and poorer general
health) across different countries and key populations in-
cluding individuals with a migration background, men who
have sex with men (MSM), women, and people with sub-
stance use dependence.8,13,14,19,22–30
Over the years, there has been substantial research on how
the psychological, social, and health aspects of quality of life
are impacted by public stigma or by self-stigma, but there is
little research that has investigated whether quality-of-life
outcomes are impacted by public stigma through self-stigma.
Conceptual models of stigma put forth by Pryor and Reeder15,16
and Berger et al.17 posit that PLHIV who perceive or expe-
rience HIV-related stigma are more likely to internalize
stigma, and this consequently leads to poorer quality of life
across psychological (depression, anxiety, and self-esteem),
social (disclosure concerns, social support), and health
(general health, sexual problems, and sleeping difficulties)
dimensions. As a result, in this study with large sample of
PLHIV in the Netherlands, we hypothesized that self-stigma
mediates the pathways from both perceived public stigma
and experienced stigma to quality-of-life outcomes.
Further, with the knowledge that social support can buffer
against stigma and its impacts,30–34 we further hypothesized
that the pathways from both perceived public stigma and ex-
perienced stigma to self-stigma are moderated by social sup-
port. This is new. Research on the role of social support for
PLHIV has focused predominantly on the relationship be-
tween social support and stigma30,32 or on relationships
between social support and quality-of-life outcomes.33 One
study, by Brener and colleagues,34 investigated social support
as a moderator in the relationship between HIV-related stigma
and health outcomes but, to our knowledge, no previous study
has explored the possible buffering effect of social support in
the relationship between public stigma and self-stigma. The-
oretically, it makes sense that social support can protect
PLHIV from the internalization of negative beliefs about HIV
and PLHIV, as public stigma is at the core of all other forms of
stigma, including self-stigma.35 Hence, our hypothesis.
Disentangling how various forms of stigma work to impact
quality-of-life outcomes across psychological, social, and
health dimensions, and whether social support can buffer
against the internalization of public stigma is not only theo-
retically important, it is important for the design of effective




Data for this study were drawn from a cross-sectional
survey of 1704 PLHIV recruited from the Department of
Internal Medicine of OLVG Hospital in Amsterdam in the
context of a holistic HIV care trajectory.37 Participants were
eligible for the study if they were at least 18 years of age, and
if they were able to complete the survey in Dutch or English.
Of the *3000 patients invited to participate, 1704 completed
the survey (57%). Informed consent was obtained. Demo-
graphic characteristics (gender, age, region of origin, HIV
transmission route, and time since diagnosis) were retrieved
from medical records. Data collection took place between
2016 and 2018. Surveys were completed online or offline
during hospital visits. Ethical approval for this study was
granted by the ethical review board of OLVG Hospital in the
Netherlands.
Measures
HIV-related stigma. HIV-related stigma was measured
using an adapted version of the 40-item HIV stigma scale
developed by Berger et al.,17 namely the short 10-item HIV
stigma scale.38 The 10-item scale measures public attitudes,
personalized stigma, negative self-image, and disclosure
concerns. Answers were provided on a 4-point scale ranging
from 1 to 4, with higher scores indicating greater stigma. This
scale is a frequently used measure of HIV-related stigma and
is considered both valid and reliable.38,39 For this study, we
utilized each subscale individually because they represent
different forms of stigma. We drew items from the short HIV
stigma scale that reflect the concepts of perceived public
stigma, experienced stigma, and self-stigma.
Perceived public stigma was measured using the two-item
subscale ‘‘public attitudes.’’ An example item is ‘‘Most
people with HIV are rejected when others find out.’’ Cron-
bach’s alpha was 0.84. Experienced stigma was assessed
using the three-item subscale ‘‘personalized stigma.’’ An
example item is ‘‘I have lost friends by telling them I have
HIV.’’ Cronbach’s alpha was 0.84. Self-stigma was measured
using the three-item subscale ‘‘negative self-image.’’ An
example item is ‘‘Having HIV makes me feel that I’m a bad
person,’’ Cronbach’ alpha was 0.89.
Quality-of-life outcomes. Staff at OLVG Hospital spe-
cialized in HIV care, together with PLHIV and experts in
psychosocial and health aspects of living with HIV, identified
eight crucial aspects of quality of life for PLHIV. These aspects
were also considered to be clinically relevant to the provision of
patient-centered health care. The eight aspects represent psy-
chological, social, and health dimensions of quality of life.37
Disclosure concerns were assessed using the two-item
subscale ‘‘disclosure concerns’’ of the HIV stigma scale.38 In
the analysis, we treated disclosure concerns as a quality-of-
life outcome instead of a type of stigma because previous
studies have found internalized stigma in PLHIV to be a
significant predictor of disclosure concerns.25,39,40 An ex-
ample item is ‘‘I am very careful who I tell that I have HIV.’’
Cronbach’s alpha was 0.66.
Depression and anxiety were measured using the 14-item
Hospital Anxiety and Depression Scale (HADS),41 com-
prising 7 items for depression and 7 items for anxiety. An
example item for depression is ‘‘I still enjoy the things I used
to enjoy.’’ An example item for anxiety is ‘‘I get sudden
feelings of panic.’’ Answers were provided on a 4-point scale
ranging from 0 to 3, with higher scores indicating higher
levels of depression and anxiety. The HADS is a frequently
used measure of depression and anxiety. Cronbach’s alpha
for both depression and anxiety was 0.83.
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Sexual problems were measured with a nine-item scale
developed based on the model of incentive motivation42 and
the Natsal-SF.43 The scale measures sexual functioning and
experience, sexual feelings, and sexual satisfaction. Answers
were provided on a 5-point scale ranging from 1 to 5, with
higher scores indicating greater sexual problems. An example
item is ‘‘Do you feel anxious about having sex because you are
afraid of passing HIV to others?’’ Cronbach’s alpha was 0.81.
Sleeping difficulties were measured using the three-item
Symptom Checklist 90 Revised.44,45 Answers were provided
on a 5-point scale ranging from 1 to 5, with higher scores
indicating more sleep difficulties. Items included questions
related to trouble falling asleep or disturbed sleep. Cron-
bach’s alpha was 0.80.
Self-esteem was measured using the Single-Item Self-
Esteem Scale (SISE),46 namely ‘‘I have high self-esteem’’
with scores ranging from 1 to 7. A higher score indicates
more self-esteem. The scale demonstrated high construct
validity.46
General health was assessed using the 12-item Short Form
Health Survey.47 The scale measured physical and mental
health domains. Scores range from 0 to 100, reflecting worst
to best health. An example item is ‘‘Have you been able to
concentrate on what you are doing?’’ This scale has been
used extensively and is considered both valid and reliable.47
Cronbach’s alpha was 0.90.
Social support was assessed using the 12-item short ver-
sion of the Social Support List-Interaction48 that measures
everyday support, support in problem situations, and esteem
support. The scores range from 12 to 48, with higher scores
indicating more social support. An example item is ‘‘Does it
ever happen to you that people show they are fond of you?’’
This scale is a frequently used measure of social support.
Cronbach’s alpha was 0.92.
Data analysis
We first conducted a missing data analysis using the ex-
pectation maximization likelihood approach because 3.87%
of the data were missing due to nonresponse. Descriptive
analyses were then conducted for all variables in our sample.
A regression analysis was used to test whether moderation of
social support in the interaction between perceived public
stigma, experienced stigma, and self-stigma was present.
Structural equation modeling (SEM) was used to test paths
from different types of stigma (independent variables) to
quality-of-life outcomes (dependent variables). We exam-
ined (1) direct effects of perceived public, experienced stig-
ma, and self-stigma on quality-of-life outcomes, and (2)
indirect effects of perceived public and experienced stigma
on quality-of-life outcomes through self-stigma. The Lavaan
package49,50 was used to test how well the stigma mediation
model fitted the data and whether there were any relevant
indirect effects present. Model fit was determined using the
Tucker Lewis Index (TLI), the standardized root mean
square residual (SRMR), and the root-mean-square error of
approximation (RMSEA). Cutoff values of 0.95 for the
TLI51,52 and 0.06 for the RMSEA and the SRMR53 indicate a
good fit, and an adequate fit is indicated when TLI exceeds
0.90, and when RMSEA and SRMR are <0.08.51,53 For this
study, statistical significance of the (indirect) effects was
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the parameter estimates. The adjusted (bias-corrected)
bootstrap percentile (bca) method was used to obtain the
confidence intervals. In our analyses, we controlled for
gender, age, region of origin, HIV transmission route, and
time since diagnosis.
Results
Most of the 1704 participants included in the sample were
male (94%). Age ranged from 21 to 84, with a mean age of
50.7 years [standard deviation (SD) = 10.9]. The sample was
culturally diverse; more than half of the participants were
born in the Netherlands (62%), 22% had a non-Western mi-
gration background, 15% had a Western migration back-
ground, and 1% was unknown. The majority of the
participants had acquired HIV through same sex intercourse
(MSM; 87%). The mean time since diagnosis was 11.8 years
(SD = 7.9).
Table 1 gives correlations, means, and SDs for all stigma
and quality-of-life variables. Pearson correlation analyses
indicated that self-stigma was significantly and positively
related to other types of stigma (perceived public stigma
r(1702) = 0.55, p < 0.01, experienced stigma r(1702) = 0.47,
p < 0.01). Self-stigma was also significantly related to all
domains of quality-of-life outcomes, and showed a positive
association with disclosure concerns, depression, anxiety,
sexual problems, and sleeping difficulties [rs(1702) ranging
from 0.31 to 0.48, p < 0.01]. Finally, self-stigma was nega-
tively associated with self-esteem, general health, and social
support [r(1702) = -0.29, -0.40, -0.29, p < 0.01]. Similarly,
perceived public stigma and experienced stigma were posi-
tively associated with disclosure concerns, depression, anx-
iety, sexual problems, and sleeping difficulties [rs(1702)
ranging from 0.21 to 0.51, p < 0.01], and negatively related to
self-esteem, general health, and social support [rs(1702)
ranging from -0.19 to -0.34, p < 0.01].
SEM results. Regression analysis was conducted to ex-
amine the moderating effect of social support in the pathways
from perceived public stigma and experienced stigma to self-
stigma. The analysis indicated that the interaction terms were
very small for both experienced stigma [b = -0.009; standard
error (SE) = 0.003] and for perceived public stigma
(b = -0.005; SE = 0.003). Therefore, moderating effects were
ignored in subsequent analyses. However, social support was
added as a covariate in the model because it had an effect on
the quality-of-life outcomes.
The final structural model (without interactions) fitted the
data well: (v2 (12) = 57.9, TLI = 0.970, SRMR = 0.024,
RMSEA = 0.047). SEM results are presented in Fig. 1 and
Table 2. Figure 1 shows the significant standardized direct
effects, with smaller effects (<0.20) omitted. The 12 indirect
effects in this model (1 for each combination of independent
and dependent variable) are displayed in Table 2. Two direct
effects were added to this model (perceived public stigma to
disclosure concerns and experienced stigma to disclosure
concerns) to obtain a good fit. This was necessary because a
model with only indirect effects could not fully explain the
correlation between experienced and perceived public stig-
ma, on one hand, and disclosure concerns, on the other.
Results displayed in Fig. 1 and Table 2 illustrate the size of
the indirect effects through self-stigma of both perceived
public stigma and experienced stigma on quality-of-life out-
comes, indicating a mediating effect of self-stigma in the re-
lationship between, on one hand, perceived public stigma and
experienced stigma and, on the other, quality of life. The in-
direct effects of perceived public stigma were larger than those
of experienced stigma. Tables showing all direct pathways
from self-stigma and social support to quality-of-life outcomes
as well as explained variance of the model for all dependent
variables are presented in the supplementary material.
Discussion
This study set out to explore a comprehensive model of
HIV-related stigma and its impact on quality of life in
PLHIV. We found that self-stigma mediates the relationships
between perceived public stigma and experienced stigma, on
one hand, and quality-of-life outcomes, namely disclosure
concerns, depression, anxiety, sexual problems, sleeping
difficulties, self-esteem, and general health, on the other
hand. To date, there are a limited number of studies investi-
gating how stigma types influence each other and the lives of
PLHIV.21 Prior research does indicate that HIV-related
FIG. 1. Self-stigma mediation model with standardized parameters showing direct effects. The lines with arrows show all
direct effects in the mediation model. Only effects of 0.20 or higher are shown in the figure.
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stigma directly affects the quality of life of PLHIV nega-
tively.14,19,21,24,54,55 Corroborating this, we found that both
public stigma and self-stigma had direct effects on all quality-
of-life outcomes. Our results extend previous work on
HIV-related stigma and quality of life by highlighting that
perceived public and experienced stigma negatively affect
quality of life through its impact on self-stigma.
In our study, perceived public stigma and experienced
stigma predicted higher self-stigma, which is in line with prior
research in which perceived community stigma was found to
predict self-stigma in women living with HIV in a health care
setting.56 Supporting these findings, experienced stigma has
also been found to be associated with self-stigma in
PLHIV.57,58 In our study, perceived public stigma was found
to be a stronger driver of self-stigma than experienced stigma.
This may be due to the way in which self-stigma is generally
understood, namely as the internalization of stigmatizing be-
liefs in society.16,26,59 It is possible that perceived negative
beliefs more directly affect the self because perceived beliefs
are potentially more likely than actual experiences of stigma to
generate feelings of fear or anticipation of being stigmatized.
Our findings further show that social support was strongly
related to some of the quality-of-life outcomes, namely de-
pression, anxiety, and general health. This partly aligns with
recent research that highlights social support as a protective
factor against stigma and negative (mental) health out-
comes.30,33,37,60 However, social support did not act as a
moderator in our model, as we hypothesized, and the role
of social support in the relationship between stigma types could
not be explained. Previous research with PLHIV has identified
a buffering effect of social support on perceived stigma,32,61
and the same effect of social support on self-stigma,30 but the
role of social support within relationship dynamics of different
stigma types requires further study. Specifically, we recom-
mend that future research further investigates the role that so-
cial support and other potential buffers (e.g., empowerment and
resilience strategies) can play in reducing different types of
stigma in PLHIV to clarify its potential for ameliorating the
negative effects of different types of stigma. We further rec-
ommend exploring the possible moderating effects of different
facets of social support (such as everyday support or support in
problem situations) on different types of stigma.
Our study is unique in that it focused on pathways from
HIV-related stigma to quality-of-life outcomes, and the role
of self-stigma within this process. To our knowledge, the only
comparable research was conducted by Turan et al.19 That
study examined the mediating role of self-stigma in the re-
lationship between HIV-related public stigma and affective,
cognitive, and mental health (with significant indirect effects
found) and treatment adherence (with no significant indirect
effect found). Our study builds on this and further concep-
tualizes the relationships between perceived public stigma,
experienced stigma, self-stigma, and the quality of life of
PLHIV in mental, social, and health domains.
Our findings clearly suggest that efforts to reduce HIV-
related stigma and improve the quality of life of PLHIV
should include strategies specifically addressing self-stigma.
Strategies to reduce self-stigma include cognitive behavioral
therapy, psychoeducation, enhancing social and peer support,
and other empowerment techniques.26,62–65 However, prior
research reveals a shortage of high-quality interventions tar-
geting HIV-related self-stigma.26,62,66,67 A recent systematic
review by Pantelic et al.26 indicated that multi-leveled
interventions are likely to be more effective in reducing
self-stigma among key populations living with HIV. We
recognize that drivers of self-stigma may vary across cul-
tures and contexts. Therefore, we recommend that future
studies on HIV-related self-stigma focus on examining
other potential (sociocultural) drivers of self-stigma for
different PLHIV to better inform interventions. This is
important because self-stigma in PLHIV is also influenced
by broader structural and social inequalities.68,69 It may also
be important to address the relationship between HIV-
related stigma and substance use. Recent studies have
drawn attention to high rates of substance use and related
(mental) health problems in PLHIV, especially among
MSM.70,71
The findings of this study should be interpreted in light of
some limitations. First, the data in our study were derived
from an urban region in the Netherlands and consisted of
predominantly MSM, therefore, limiting the generalizability
of our findings to other key populations living with HIV.
However, the demographic composition of our sample is
typical for the Dutch PLHIV population, of which the ma-
jority are MSM. Second, bias toward nonresponse should be
noted with regard to both missing data in our sample and
those who refused to participate. Nonresponse may be due to
language or cultural barriers as the HIV patient population at
OLVG hospital is also highly culturally diverse. Future
studies should focus on finding ways to include harder-to-
Table 2. Estimates of Standardized Indirect










0.04 0.01 0.03 to 0.06
Experienced stigma »
Disclosure concernsa
0.12 0.02 0.11 to 0.21
Public stigma » Disclosure
concerns
0.06 0.01 0.04 to 0.08
Public stigma » Disclosure
concernsa
0.38 0.03 0.34 to 0.43
Experienced stigma »
Anxiety
0.11 0.01 0.09 to 0.13
Public stigma » Anxiety 0.17 0.01 0.15 to 0.19
Experienced stigma »
Depression
0.08 0.01 0.07 to 0.10
Public stigma » Depression 0.13 0.01 0.11 to 0.15
Experienced stigma »
Self-esteem
-0.06 0.01 -0.07 to -0.04
Public stigma » Self-esteem -0.09 0.01 -0.11 to -0.07
Experienced stigma » Sleep
difficulties
0.07 0.01 0.05 to 0.08
Public stigma »
Sleep difficulties
0.11 0.01 0.08 to 0.12
Experienced stigma » Sexual
problems
0.11 0.01 0.09 to 0.13
Public stigma »
Sexual problems
0.17 0.01 0.14 to 0.19
Experienced stigma »
General health
-0.08 0.01 -0.10 to -0.06
Public stigma »
General health
-0.12 0.01 -0.14 to -0.10
aThese are direct effects and were added because they were
necessary to obtain a good fit.
CI, confidence interval.
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reach populations. Third, our data were cross-sectional,
limiting possibilities for causal inference. We recommend
longitudinal studies that could further explore pathways of
HIV-related stigma, sociodemographic indicators, and asso-
ciated health outcomes over time.
This study showed that perceived public stigma and ex-
perienced stigma contribute to self-stigma in PLHIV, which,
in turn, leads to reduced quality of life. The findings thus
demonstrate the importance of addressing self-stigma in
PLHIV. Future interventions that aim to reduce HIV-related
stigma and improve quality of life for PLHIV should,
therefore, incorporate theory- and evidence-based strategies
to reduce self-stigma.
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